What happened
SK Bioscience disclosed a plan to buy back its own shares worth US$11.6M, about 0.6% of its market value.
For context, this equals about 0.6% of the company's market value.
| Buyback amount | US$11.6M |
|---|---|
| vs. market value | 0.6% |
| Filed | 2026-04-28, Material event report (treasury share acquisition) |
| Source | DART rcept 20260428000715 → open original filing |
Source: DART. Information only, not investment advice.